share_log

Ovid Therapeutics | 8-K: Ovid Therapeutics Reports Business Update, Fourth Quarter and Full Year 2022 Financial Results

SEC ·  Mar 13, 2023 08:23
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.